DFDA

Blood Pressure Control (e.g., Nicardipine IV)

Treatment for Subarachnoid Hemorrhage

Typical Dosage: Nicardipine: 5 mg/hour IV, titrated up to 15 mg/hour

Effectiveness
80%
Safety Score
68%
Clinical Trials
20
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
68
DangerousModerateSafe
Treatment Details
Dosage Range
Nicardipine: 5 mg/hour IV, titrated up to 15 mg/hour
Time to Effect
Immediate
Treatment Duration
Days to weeks (acute hospitalization)
Evidence Quality
HIGH
Number Needed to Harm (NNH)
25(Treat 25 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$800
Monitoring:$1,000
Side Effect Mgmt:$200
Total Annual:$2,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$20,000/QALY
QALYs Gained
0.5
Outcome-Based Costs
Cost per Responder
$1,053
Blood Pressure Control (e.g., Nicardipine IV) Outcomes

for Subarachnoid Hemorrhage

Efficacy Outcomes
Overall Effectiveness
+80%
Response Rate
+95%
Common Side Effects
Hypotension
+15%
Tachycardia
+7%
Headache
+7%
Nausea
+7%

Sources:

nih.gov
nursingcenter.com
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov